HCONRES 35 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
Exposing Congressional Drug Abuse Act
Requiring Members of the House of Representatives and the Senate to participate in random drug testing.
Summary
This concurrent resolution requires all Members of the House of Representatives and the Senate to participate in a random drug testing program for illegal controlled substances. Each member would be subject to one random drug test per term, with results provided to the member and to their respective chamber's ethics committee for review. Members who refuse to participate would be publicly identified by the ethics committees and subject to appropriate action. Members must reimburse their chamber for the cost of their drug test. The House Administration and Senate Rules committees are directed to issue regulations to implement the program.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
- Rep. Higgins, Clay [R-LA-3] (R-LA)
Money behind the sponsor
Top reported contributors to Clay Higgins’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.
- NULL $14,100
- SAFESOURCE DIRECT $10,500
- THE PICARD GROUP $8,300
- WINN CORRECTIONAL $6,666
- PHI, INC. $6,600
Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Clay Higgins → · Outside spending →
Actions (2)
- Jun 5, 2025 Referred to the House Committee on House Administration. · house
- Jun 5, 2025 Submitted in House
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Text versions (1)
Bills are re-published as they move (Introduced → Reported → Engrossed → Enrolled …). Each stage below is a separate text; pick two to see what changed. Data from Congress.gov.
Full text
IN THE HOUSE OF REPRESENTATIVES
June 5, 2025
Mr. Higgins of Louisiana submitted the following concurrent resolution; which was referred to the Committee on House Administration
CONCURRENT RESOLUTION
Requiring Members of the House of Representatives and the Senate to participate in random drug testing.
Resolved by the House of Representatives (the Senate concurring),
SECTION 1. SHORT TITLE.
This concurrent resolution may be cited as the “Exposing Congressional Drug Abuse Act”.
SEC. 2. RANDOM DRUG TESTING OF MEMBERS OF THE HOUSE OF REPRESENTATIVES AND THE SENATE.
(a) In General.—Each Member of the House of Representatives and the Senate shall participate in accordance with this concurrent resolution in a program for testing for illegal use of controlled substances.
(b) Features.—The program under this concurrent resolution shall include the following features:
(1) Each Member of the House of Representatives and the Senate shall be subject to a random drug test once per term of such Member.
(2) Each confirmed positive result under the program shall be provided as follows:
(A) To the Member involved.
(B) In the case of a Member of the House of Representatives, to the Committee on Ethics of the House of Representatives for such review as may be necessary under the Rules of the House of Representatives.
(C) In the case of a Member of the Senate, to the Select Committee on Ethics of the Senate for such review as may be necessary under the Standing Rules of the Senate.
(3) The Committee on Ethics of the House of Representatives, with respect to a Member of the House, and the Select Committee on Ethics of the Senate, with respect to a Member of the Senate, shall publicly disclose the identity of each Member who refuses to participate in the program and take other action against each such Member as appropriate.
(4) Each Member of the House of Representatives and the Senate shall reimburse the House of Representatives or the Senate for the cost of the random drug test of such Member under the program.
(c) Regulations.—The Committee on House Administration of the House of Representatives and the Committee on Rules and Administration of the Senate shall each issue such rules and regulations as may be necessary to carry out this concurrent resolution.
(d) Definitions.—In this concurrent resolution:
(1) Confirmed positive result.—The term “confirmed positive result”—
(A) means a random drug test—
(i) which has initially tested as positive for the presence of an illegal controlled substance;
(ii) for which the initially positive test has been confirmed by a second test using a different chemical process than the process used for the initial test; and
(iii) which has been reviewed and certified as positive by a medical review officer with whom the House of Representatives or the Senate has entered into a contract to perform such reviews; and
(B) does not include a drug test which shows only the presence of legal, over-the-counter drugs and drugs that have been legally prescribed for the individual involved.
(2) Controlled substance.—The term “controlled substance” has the meaning given the term in section 102 of the Controlled Substances Act (21 U.S.C. 802).
(3) Member.—The term “Member”, with respect to the House of Representatives, includes a Delegate or Resident Commissioner to the Congress.
(4) Random drug test.—The term “random drug test” means a test conducted for the purpose of detecting the illegal use of a controlled substance which is conducted—
(A) on a periodic basis;
(B) without advance notice; and
(C) without individualized suspicion. <all>
Comments